AMG 133 demonstrated significant dose-dependent weight loss in a phase 1 randomized, double-blind, placebo-controlled clinical trial involving participants with obesity, along with an acceptable safety and tolerability profile [124]
Studies were excluded if they met the following exclusion criteria: studies conducted on children, adolescents, or animals, reviews studies, in vitro studies, editorial papers, gray literature, books, conference abstracts, and RCTs conducted without a placebo or control group
Animal experiments All animal procedures were performed in accordance with the ethical standards approved by the Animal Care and Ethics Committee of the Second Affiliated Hospital, Zhejiang University School of Medicine
Recommended Dosage : Standard Formula in 120 units/box higher potency meets consumer expectations for visible results in fat metabolism
Hanahan D
Forty-eight hours after infection, we observed a 75% reduction in BDNF secretion